Class II

Medical Device Recall: VITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2

Ortho-Clinical Diagnostics, Inc. · July 3, 2024

Reason for Recall

It was confirmed that fibrinogen in patient plasma samples precipitates out of solution upon the addition of folate stabilizer reagent as part of the pre-treatment process causing the increase in "TM5-4MB" condition codes which lead to a delay of results.

Distribution

Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Sweden, United Kingdom.

States Affected

NATIONWIDE

Quantity Affected

18,467 units

Source: FDA (openFDA Device Enforcement)

Recall number: Z-2580-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Ortho-Clinical Diagnostics, Inc. Medical Device Recall: VITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2 | SafeCheck